The PO superiority of torsemide to lasix is something i agree with in theory and seem to appreciate in practice, though less pronounced when compared to bumetanide. Need better RCT for this comparison, or maybe I have not found a good one, honestly, haven't been searching.
With regard to IV bumex vs. lasix... in critically ill patients with edema, hypoalbuminemia, some nephrologists I know speculate that bumex has a smaller Vd (compared to lasix) attributable to enhanced globulin-binding and therefore increased renal tubular secretion and superior diuretic effect. Although it is true that there is enhanced non-albumin protein binding w/ bumex, in an old study the diuretic effect (6 hr urine flow rate, Na, K, excretion) was no different despite comparable doses (this in analbuminemic RATS). What is more interesting, in patients with advanced renal failure, on more than one occasion "equivalent" doses of lasix and bumex (dose ratio of 40:1) actually yielded greater diuretic effect in the lasix recipients, so much so that in advanced renal failure patients, the equivalent lasix:bumex dose ratio approached 20:1 (Voelker et all, KI 1987- OLD). The reason for this is due to untouched hepatic metabolism of bumex while non-renal metabolism of furosemide is decreased by close to 50% ( the exact mechanism of decreased metabolism I am not aware of). This translates to increased renal tubular concentration of furosemide compared to bumex , hence, enhanced diuretic effect. Seems like intravenously, there is no good reason to choose bumex over lasix and in fact, lasix is likely more efficacious in patients with renal failure (maybe twice as effective per old KI article). These differences become less relevant as the diuretic-resistance forces increase and concomitant use of other diuretic options should be considered.